Filtros de búsqueda

Lista de obras de Susana Miranda

Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents.

artículo científico publicado en 2015

Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer

Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses

artículo científico publicado en 2016

Characterizing CDK12-Mutated Prostate Cancers

artículo científico publicado en 2020

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.

artículo científico publicado en 2017

Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts

artículo científico publicado en 2018

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer ⬇️

artículo científico publicado en 2015

Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer

artículo científico publicado en 2016

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.

artículo científico publicado en 2013

Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification

artículo científico publicado en 2017

Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency

article

Genomics of lethal prostate cancer at diagnosis and castration resistance

artículo científico publicado en 2020

HER3 Is an Actionable Target in Advanced Prostate Cancer

artículo científico publicado en 2021

Integrative Clinical Genomics of Advanced Prostate Cancer

artículo científico publicado en 2015

Integrative clinical genomics of advanced prostate cancer

artículo científico publicado en 2015

JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

artículo científico publicado en 2021

Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers

artículo científico publicado en 2012

Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer

artículo científico publicado en 2012

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients

artículo científico publicado en 2015

PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate.

artículo científico publicado en 2014

Phase I trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and AKT inhibitor capivasertib in patients with BRCA1/2 and non-BRCA1/2 mutant cancers

artículo científico publicado en 2020

Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer

artículo científico publicado en 2013

Preclinical evaluation of imaging biomarkers for prostate cancer bone metastasis and response to cabozantinib.

artículo científico publicado en 2014

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

scientific article published on 01 July 2019

RB1 Heterogeneity in Advanced Metastatic Castration Resistant Prostate Cancer

scientific article published on 26 September 2018

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

artículo científico publicado en 2018

Sarcomatoid carcinoma of the prostate: ERG fluorescence in-situ hybridization confirms epithelial origin

artículo científico publicado en 2014

Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells.

artículo científico publicado en 2016

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration

artículo científico publicado en 2015

Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis

artículo científico publicado en 2018

Targeting the p300/CBP Axis in Lethal Prostate Cancer

artículo científico publicado en 2021

The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer.

artículo científico publicado en 2012

The long tail of oncogenic drivers in prostate cancer.

artículo científico publicado en 2018

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

artículo científico publicado en 2013

Tumor clone dynamics in lethal prostate cancer

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda